Office of Research on Women's Health (ORWH)
34
3
4
25
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
5.9%
2 terminated/withdrawn out of 34 trials
92.6%
+6.1% vs industry average
26%
9 trials in Phase 3/4
40%
10 of 25 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (34)
National Program to Overcome Pelvic Pain studY (POPPY)
Role: collaborator
Apremilast for Alcohol Use Disorder Treatment in Women and Men
Role: collaborator
Veterans Response to Dosage in Chiropractic Therapy
Role: collaborator
The Osteoarthritis Prevention Study
Role: collaborator
Better Lifestyle Counseling for African American Women During Pregnancy
Role: collaborator
Look AHEAD: Action for Health in Diabetes
Role: collaborator
Sucrose-sweetened Beverage in African-American and Caucasian Women.
Role: collaborator
Women's Isoflavone Soy Health (WISH) Trial
Role: collaborator
Modeling Stress-precipitated Smoking Behavior for Medication Development
Role: collaborator
Diabetes Prevention Program Outcomes Study
Role: collaborator
Behavioral Therapy Of Obstetric Sphincter Tears
Role: collaborator
The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)
Role: collaborator
New Haven MOMS Partnership
Role: collaborator
The IPV Provider Network: Engaging the Health Care Provider Response to Interpersonal Violence Against Women
Role: collaborator
Does CERC-501 Attenuate Stress-precipitated Smoking Lapse?
Role: collaborator
Pain Catastrophizing as a Cause for Systemic Inflammation
Role: collaborator
Evaluating the Impact of the National Health Insurance Scheme of Ghana on Surgical Care
Role: collaborator
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Role: collaborator
Diabetes Prevention Program
Role: collaborator
The Effect of Yohimbine on Cocaine Cue Reactivity
Role: collaborator